189 related articles for article (PubMed ID: 22001974)
1. Novel mechanistic and clinical implications concerning the safety of statin discontinuation.
Jasińska-Stroschein M; Owczarek J; Wejman I; Orszulak-Michalak D
Pharmacol Rep; 2011; 63(4):867-79. PubMed ID: 22001974
[TBL] [Abstract][Full Text] [Related]
2. A review of perioperative statin therapy for noncardiac surgery.
Skrlin S; Hou V
Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):283-90. PubMed ID: 21041202
[TBL] [Abstract][Full Text] [Related]
3. Statins and stroke.
Endres M
J Cereb Blood Flow Metab; 2005 Sep; 25(9):1093-110. PubMed ID: 15815580
[TBL] [Abstract][Full Text] [Related]
4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
5. Statin discontinuation in high-risk patients: a systematic review of the evidence.
Gomez Sandoval YH; Braganza MV; Daskalopoulou SS
Curr Pharm Des; 2011 Nov; 17(33):3669-89. PubMed ID: 22074437
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications for statin pleiotropy.
Liao JK
Curr Opin Lipidol; 2005 Dec; 16(6):624-9. PubMed ID: 16276239
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of statin treatment in stroke patients.
Endres M; Laufs U
Stroke; 2006 Oct; 37(10):2640-3. PubMed ID: 16946153
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
9. Utilization of and Adherence to Guideline-Recommended Lipid-Lowering Therapy After Acute Coronary Syndrome: Opportunities for Improvement.
Hirsh BJ; Smilowitz NR; Rosenson RS; Fuster V; Sperling LS
J Am Coll Cardiol; 2015 Jul; 66(2):184-92. PubMed ID: 26160634
[TBL] [Abstract][Full Text] [Related]
10. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
Sahebkar A; Watts GF
Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
[TBL] [Abstract][Full Text] [Related]
11. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
12. Statin withdrawal: clinical implications and molecular mechanisms.
Cubeddu LX; Seamon MJ
Pharmacotherapy; 2006 Sep; 26(9):1288-96. PubMed ID: 16945051
[TBL] [Abstract][Full Text] [Related]
13. Statins and cardioprotection--more than just lipid lowering?
Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
[TBL] [Abstract][Full Text] [Related]
14. The evolving role of statins in the management of atherosclerosis.
Vaughan CJ; Gotto AM; Basson CT
J Am Coll Cardiol; 2000 Jan; 35(1):1-10. PubMed ID: 10636252
[TBL] [Abstract][Full Text] [Related]
15. Beyond lipid lowering: the role of statins in vascular protection.
Liao JK
Int J Cardiol; 2002 Nov; 86(1):5-18. PubMed ID: 12243846
[TBL] [Abstract][Full Text] [Related]
16. Statins in hemorrhagic stroke.
Flaster M; Morales-Vidal S; Schneck MJ; Biller J
Expert Rev Neurother; 2011 Aug; 11(8):1141-9. PubMed ID: 21797655
[TBL] [Abstract][Full Text] [Related]
17. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
Lancellotti P; Pierard LA; Scheen AJ
Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal of statin treatment abrogates stroke protection in mice.
Gertz K; Laufs U; Lindauer U; Nickenig G; Böhm M; Dirnagl U; Endres M
Stroke; 2003 Feb; 34(2):551-7. PubMed ID: 12574574
[TBL] [Abstract][Full Text] [Related]
19. How to Use Statins in Secondary Prevention of Atherosclerotic Diseases: from the Beneficial Early Initiation to the Potentially Unfavorable Discontinuation.
Kadoglou NPE; Stasinopoulou M
Cardiovasc Drugs Ther; 2023 Apr; 37(2):353-362. PubMed ID: 34347204
[TBL] [Abstract][Full Text] [Related]
20. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
